1. 3016Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension. (28th August 2018) Authors: Galie, N; Gaine, S; Channick, R; Ghofrani, H A; Hoeper, M; Lang, I; McLaughlin, V; Preiss, R; Rubin, L; Shiraga, Y; Simonneau, G; Sitbon, O; Tapson, V; Chin, K Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S122 Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension. (December 2018) Authors: Coghlan, JG; Galiè, N; Gaine, S; Channick, R; Ghofrani, H-A; Hoeper, M; Lang, I; McLaughlin, V; Preiss, R; Rubin, L; Shiraga, Y; Simonneau, G; Sitbon, O; Tapson, V; Chin, K Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗